Methyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate

Catalog No. :
ACBBUK989
CAS No. :
103053-97-0
Molecular Formula :
C14H14N2O4S
Molecular Weight :
306.34

IUPAC Name:methyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate

Methyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$231.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate
IUPAC Namemethyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate
MDL No.MFCD12911602
Molecular FormulaC14H14N2O4S
Molecular Weight306.34
SMILESO=C(OC)CC1=CSC(NC(OCC2=CC=CC=C2)=O)=N1
InChI KeyUKRDTJGASAPTHW-UHFFFAOYSA-N
SynonymMethyl 2-(2-(((benzyloxy)carbonyl)aMino)thiazol-4-yl)acetate;2-[2-(phenylmethoxycarbonylamino)-4-thiazolyl]acetic acid methyl ester;benzyl 4-((methoxycarbonyl)methyl)thiazol-2-ylcarbamate;4-Thiazoleacetic acid, 2-[[(phenylmethoxy)carbonyl]amino]-, methyl ester
CAS No.103053-97-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBBUK989 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNWYZ523 route compound structure diagram
    ACNWYZ52364987-16-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBBUK989 route product structure diagram
    ACBBUK989103053-97-0
Inquiry

2. ACBBUK989 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBBUK989 route product structure diagram
    ACBBUK989103053-97-0
Inquiry

Comments (0)